Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.

Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.

Mostra altre versioni (1)

Dettagli Bibliografici
Autori principali:	Harrison, C, Butt, N, Campbell, P, Conneally, E, Drummond, M, Green, A, Murrin, R, Radia, D, Mead, A, Reilly, J, Cross, N, McMullin, M
Natura:	Journal article
Lingua:	English
Pubblicazione:	2014

Documenti analoghi

Modification of British committee for standards in haematology diagnostic criteria for essential thrombocythaemia
di: Harrison, C, et al.
Pubblicazione: (2014)

Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
di: Reilly, J, et al.
Pubblicazione: (2014)

Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
di: Reilly, J, et al.
Pubblicazione: (2014)

Shared care protocol for the management of essential thrombocythaemia patients in primary care
di: Sweeney, C, et al.
Pubblicazione: (2011)

Ruxolitinib compared with best available therapy for essential thrombocythaemia patients resistant or intolerant to hydroxycarbamide in majic: an investigator lead randomized trial
di: Harrison, C, et al.
Pubblicazione: (2016)

Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline
di: McLornan, DP, et al.
Pubblicazione: (2023)

Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution
di: Gray, N, et al.
Pubblicazione: (2020)

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
di: McMullin, M, et al.
Pubblicazione: (2018)

Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value.
di: Harrison, C, et al.
Pubblicazione: (1999)

Hydroxycarbamide plus Aspirin vs Aspirin alone in patients with essential Thrombocythaemia aged 40-59 years without high-risk features
di: Buck, G, et al.
Pubblicazione: (2018)

A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK
di: Harrison, C, et al.
Pubblicazione: (2019)

Equivalence of BCSH and WHO diagnostic criteria for ET
di: Harrison, C, et al.
Pubblicazione: (2016)

Impact of platelet glycoprotein polymorphisms upon clinical events in essential thrombocythaemia patients enrolled in the PT1 trial
di: Robinson, SE, et al.
Pubblicazione: (2007)

Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial
di: McPherson, S, et al.
Pubblicazione: (2018)

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
di: Campbell, P, et al.
Pubblicazione: (2005)

Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology.
di: Jennings, I, et al.
Pubblicazione: (2014)

Modification of the histone landscape with JAK inhibition in myeloproliferative neoplasms
di: Greenfield, G, et al.
Pubblicazione: (2020)

Guideline for the diagnosis and management of myelofibrosis.
di: Reilly, J, et al.
Pubblicazione: (2012)

Longitudinal mutational analysis in hydroxycarbamide-resistant/intolerant essential thrombocythemia treated on the majic-ET study
di: O'Sullivan, J, et al.
Pubblicazione: (2018)

Haematological Disease
di: Murphy, M, et al.
Pubblicazione: (2009)

Haematological Disease
di: Estcourt, L, et al.
Pubblicazione: (2013)

Practical haematology /
di: 344140 Dacie, John Vivian
Pubblicazione: (1975)

British Association for Irish Studies (Interim Committee)
di: British Association for Irish Studies, BAIS, et al.
Pubblicazione: (1986)

British Association for Irish Studies (interim committee)
di: British Association for Irish Studies, BAIS
Pubblicazione: (1986)

Haematological parameters and anaemia in white and British Indian meat-eaters and vegetarians in UK Biobank
di: Tong, T, et al.
Pubblicazione: (2019)

The soldier and the post-conflict state
di: McMullin, J, et al.
Pubblicazione: (2006)

The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline
di: Curry, NS, et al.
Pubblicazione: (2018)

Haematology of Down syndrome.
di: Webb, D, et al.
Pubblicazione: (2007)

The future of academic haematology
di: Hay, D, et al.
Pubblicazione: (2016)

The expression of phosphorylated KDR in haematological malignancies
di: Pillai, G, et al.
Pubblicazione: (2003)

Immunotherapy and immunomodulation for haematological malignancies
di: Mussai, F, et al.
Pubblicazione: (2012)

T cell disorders in haematological diseases.
di: Catovsky, D, et al.
Pubblicazione: (1982)

The genesis of paediatric haematology in the UK
di: Roberts, I, et al.
Pubblicazione: (2020)

Clinical haematology in medical practice /
di: 344297 De Gruchy, Gordon Carle
Pubblicazione: (1970)

Guideline for the diagnosis and management of myelofibrosis
di: Reilly, J, et al.
Pubblicazione: (2012)

HDAC inhibitor-based therapies and haematological malignancy.
di: Stimson, L, et al.
Pubblicazione: (2009)

Dar-Oxford-London link for health: providing postgraduate haematology training (MMed and MSc in haematology)
di: Magesa, P, et al.
Pubblicazione: (2011)

Hon. Secretary's report to the Executive Committee of the British Association for Irish Studies
di: British Association for Irish Studies, BAIS, et al.
Pubblicazione: (1991)

British Association for Irish Studies, report from the Education Sub-Committee
di: British Association for Irish Studies, BAIS, et al.
Pubblicazione: (1991)

Newton on matter and activity/
di: 426207 McMullin, Ernan
Pubblicazione: (1978)